1. ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
- Author
-
Volmrich AM, Cuénant LM, Forghani I, Hsieh SL, and Shapiro LT
- Subjects
adrenoleukodystrophy ,spastic paraparesis ,adrenal insufficiency ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Alyssa M Volmrich,1 Lauren M Cuénant,1 Irman Forghani,2 Sharon L Hsieh,3 Lauren T Shapiro1 1Department of Physical Medicine & Rehabilitation, University of Miami Miller School of Medicine, Miami, FL, USA; 2Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA; 3MD/MPH Program, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence: Lauren T Shapiro, Department of Physical Medicine & Rehabilitation; University of Miami Miller School of Medicine, P.O. Box 016960 (C-206), Miami, FL, 33101, USA, Tel +1 305 243-6605, Fax +1 305 243-4650, Email lxs973@med.miami.eduAbstract: Pathogenic variants in the ABCD1 gene on the X chromosome may result in widely heterogenous phenotypes, including adrenomyeloneuropathy (AMN). Affected males typically present in their third or fourth decade of life with progressive lower limb weakness and spasticity, and may develop signs and symptoms of adrenal insufficiency and/or cerebral demyelination. Heterozygous females may be asymptomatic, but may develop a later-onset and more slowly progressive spastic paraparesis. In this review, we describe the clinical presentation of AMN, as well as its diagnosis and management. The role of rehabilitative therapies and options for management of spasticity are highlighted.Keywords: adrenoleukodystrophy, spastic paraparesis, adrenal insufficiency
- Published
- 2022